Tenderfy

LNWH - Point-Of-Care Testing for Genotype CYP2C19

Buyer
London North West University Healthcare NHS Trust
Published
2026-11-04
Deadline
Not provided
Sources
UK_FTS
Value
Not provided

Description

The description is in the source language.

Provision of a point-of-care pharmacogenetic testing service for the rapid identification of CYP2C19 genetic variants associated with altered metabolism and response to clopidogrel.

Membership

Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.

Read